Intellectual Property India Publishes Patent Application for 'Treatment Of Uremic Pruritus' Filed by Cymabay Therapeutics, Inc.

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517078920 A) filed by Cymabay Therapeutics, Inc., Foster City, U.S.A., on Aug. 20, for 'treatment of uremic pruritus.'

Inventor(s) include Choi, Yun-Jung; and Mcwherter, Charles, A.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "Treatment of uremic pruritus by administration of seladelpar or a salt thereof, or by administration of mavodelpar or a salt thereof."

The patent application was internationally filed on Jan. 25, 2024, under International application No.PCT/US2024/013004.

Disclaimer: Curated by HT Syndication.